Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04660032 · ClinicalTrials.gov registry record · NA

Nudge to Drive Transitions of Care

A NA study of Preeclampsia and Gestational Hypertension, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
224
Enrollment target
1
Study location

NCT04660032: Completed NA study of Preeclampsia and Gestational Hypertension, sponsored by University of Pennsylvania.

NCT04660032 is a NA study of Preeclampsia and Gestational Hypertension that has completed, run by University of Pennsylvania. The registered enrollment target is 224 participants, below the 1,122-participant average among 48 other Preeclampsia trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04660032, a NA study of Preeclampsia and Gestational Hypertension, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
224 participants
Enrollment target
1
Study location

Study Summary

Hypertensive disorders of pregnancy (HDP) are stress tests which may identify women at high risk of future cardiovascular disease (CVD), the leading cause of death among women. Given the public health impact of HDP and CVD, there is a compelling need to identify scalable interventions to improve preventative care among women who have risk identified during pregnancy. We will examine the effects of delivering electronic prompts to obstetric care providers (nudge) on transitions of care in the postpartum period. We will conduct a pilot randomized trial to evaluate whether this nudge intervention will improve postpartum counseling and lead to greater follow-up with preventative care providers among women with HDP.

Primary Outcome

The primary outcome measure is documentation of counseling about transitioning care to a continuity care provider (primary care or cardiology) at the postpartum visit.

Interventions

  • BEHAVIORAL Nudge

Study Locations (1)

Pennsylvania

  • Pennsylvania Hospital - Philadelphia

Trial Details

FieldValue
Enrollment Target 224 participants
Start Date 2021-02-08
Est. Completion 2023-04-20
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT04660032 record still lists

NCT04660032 is an interventional study that assigns participants to a tested intervention. The registered 224 participants enrollment target is mid-sized for trials with a published cap, below the 1,122-participant average among 48 other Preeclampsia trials with a reported enrollment target (80% lower).

The record links to 5 conditions, with Preeclampsia appearing as the primary indexed condition, and to 1 intervention - of which Nudge is the first listed.

NCT04660032 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04660032 about?

NCT04660032 is a clinical study titled "Nudge to Drive Transitions of Care". Hypertensive disorders of pregnancy (HDP) are stress tests which may identify women at high risk of future cardiovascular disease (CVD), the leading cause of death among women. Given the public health impact of HDP and CVD, there is a compelling need to identify scalable interventions to improve pre...

What is the current status of trial NCT04660032?

This trial is currently completed. It is a NA study. The enrollment target is 224 participants. The study started on 2021-02-08. Estimated completion is 2023-04-20.

What conditions does trial NCT04660032 study?

This clinical trial studies the following conditions: Preeclampsia, Gestational Hypertension, Hypertensive Disorder of Pregnancy, Superimposed Pre-Eclampsia, Preeclampsia Severe.

What interventions are being tested in trial NCT04660032?

The interventions under investigation include: Nudge (BEHAVIORAL).

Who is sponsoring clinical trial NCT04660032?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04660032 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Preeclampsia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04660032's enrollment target sits among peer trials

224 18th of 48 higher than 30 of 48 other Preeclampsia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Preeclampsia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02706561 · 224 participants · NA

    Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery

  • NCT04140344 · 224 participants · NA

    The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions

  • NCT04915183 · 224 participants · Phase 2

    Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

  • NCT05519878 · 224 participants · NA

    Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04660032, the US trial registry maintained by the National Library of Medicine. NCT04660032 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.